Amarin | Kortsiktig Gjeld



Current Liabilities Endring Dato
AbbVie USD 38.75B 4.31B 2024-12
Alnylam Pharmaceuticals USD 1.08B 110.65M 2025-03
Amarin USD 201.55M 28.99M 2024-09
AstraZeneca USD 29.13B 1.26B 2025-03
DBV Technologies USD 30.91M 3.53M 2024-09
GlaxoSmithKline GBP 20.83B 866M 2025-03
Halozyme Therapeutics USD 150.38M 11.28M 2025-03
Ionis Pharmaceuticals USD 250.29M 59.02M 2025-03
Neurocrine Biosciences USD 507.7M 78M 2024-12
Novartis USD 28.69B 560M 2024-12



Amarin Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.